Foghorn Therapeutics Inc. is indeed a fully public corporate entity listed on the NASDAQ Global Select Market under the official ticker symbol FHTX. This public status allows institutional funds and retail shareholders to buy and sell shares under transparent regulatory reporting frameworks.